Log in to save to my catalogue

Efficacy and safety of tribendimidine against Opisthorchis viverrini : two randomised, parallel-grou...

Efficacy and safety of tribendimidine against Opisthorchis viverrini : two randomised, parallel-grou...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1827902707

Efficacy and safety of tribendimidine against Opisthorchis viverrini : two randomised, parallel-group, single-blind, dose-ranging, phase 2 trials

About this item

Full title

Efficacy and safety of tribendimidine against Opisthorchis viverrini : two randomised, parallel-group, single-blind, dose-ranging, phase 2 trials

Publisher

United States: Elsevier Ltd

Journal title

The Lancet infectious diseases, 2016-10, Vol.16 (10), p.1145-1153

Language

English

Formats

Publication information

Publisher

United States: Elsevier Ltd

More information

Scope and Contents

Contents

Summary Background Treatment of the liver fluke infection Opisthorchis viverrini relies exclusively on praziquantel. Tribendimidine could be an alternative treatment option. We aimed to assess the efficacy and safety of ascending single, oral doses of tribendimidine in patients with O viverrini infection. Methods We did two randomised, parallel-gro...

Alternative Titles

Full title

Efficacy and safety of tribendimidine against Opisthorchis viverrini : two randomised, parallel-group, single-blind, dose-ranging, phase 2 trials

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1827902707

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1827902707

Other Identifiers

ISSN

1473-3099

E-ISSN

1474-4457

DOI

10.1016/S1473-3099(16)30198-0

How to access this item